肥満治療薬「ウゴービ」や2型糖尿病治療薬「オゼンピック」として知られるセマグルチド、2型糖尿病と肥満症の治療に使われるチルゼパチドなどのGLP-1受容体作動薬を使用したことで、肉類や揚げ物、塩辛い食べ物が嫌いになってしまったとの経験談やそのメカニズム ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

People taking an Ozempic-like drugs have reported experiencing a change in their tastes and a lower desire to eat food they once loved. Ozempic is a GLP-1 agonist medication made from semaglutide, ...

Experts, however, are starting to gain some clues as to how common these apparent shifts in food preference and taste really are among users and what might be behind them. Related: Ozempic in a pill?

The popularity of weight loss drugs has caused a shortage in recent years, but how effective are they at helping with food ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Just over a quarter of the 303 respondents think Big Food can wait out the emerging threat from appetite-suppressing drugs like Zepbound, Ozempic and Wegovy. “The challenge in the developed ...

Jeremy Clarkson tried Ozempic and had a rough time. Writing in The Times, he said it made him vomit and gave him no joy around food. “That’s not living. That’s existing,” he said.